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Abstract: (1) Background: To assess the relationship between the duration of the second stage of
labour and the neonatal morbidity risk; (2) Methods: An observational, analytical, retrospective cohort
study was performed at the “Mancha-Centro” Hospital (Spain) during the 2013–2016 period.
Data were collected from 3863 women who gave a vaginal birth. The studied neonatal morbidity
variables were umbilical cord arterial pH, 5-min Apgar score, need for advanced neonatal
resuscitation, and a composite neonatal morbidity variable on which the multivariate analysis
was done. A univariate analysis was used for the potential risk factors and a multivariate analysis
with binary logistic regression to control for possible confounding factors; (3) Results: The univariate
analysis showed a statistically significant relationship between the duration of the second stage
of labour and a high risk of advanced neonatal resuscitation and composite neonatal morbidity in
multiparous women. However, after performing the multivariate analysis for the variable “composite
neonatal morbidity”, we observed no relationship with the duration of the second stage of labour
in either nulliparous or multiparous women; (4) Conclusions: The duration of the second stage of
labour was not related to an increased risk of neonatal morbidity in our study population.
Keywords: labour: second stage; newborn care; neonatal morbidity; quantitative research
1. Introduction
The second stage of labour begins when the cervix becomes fully dilated and ends with the
delivery of the neonate [1]. Optimally managing the second stage of labour is a constant challenge for
professionals in the clinical practice [2]. The main objective of this stage of labour is to lower caesarean
section rates, increase the possibility of vaginal birth and, in turn, avoid adverse effects for both the
mother and the newborn [2,3].
The second stage of labour is characterised by an increasing number and intensity of uterine
contractions with respect to the first stage of labour, as well as an increase in maternal bearing down
efforts, which leads to maternal fatigue and high foetal lactic acid levels [4]. If the foetus’ head lowers,
it can compress the umbilical cord, which reduces cerebral perfusion [4]. Therefore, the presence
or combination of these factors means that the second stage of labour is a very stressful period for
the foetus.
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For this reason, the duration of the second stage of labour is particularly interesting as its optimum
duration is a matter of constant debate [5]. Nowadays, it is uncertain if a time point exists during
the second stage of labour at which the risk of neonatal morbidity increases, leading to the need for
professionals to intervene so as to prevent adverse events [6,7].
Until 2012, a prolonged second stage of labour had been defined as a period of time that lasted
beyond 2 h with epidural analgesia (EA) or 1 h without EA for multiparous women. As for nulliparous
women, a second prolonged stage is defined as a period of time longer than 3 h with EA or longer than
2 h without EA [8]. More recently, though, the National Institute for Health and Care Excellence (NICE)
and the American College of Obstetricians and Gynecologists (ACOG) have included longer durations
in some cases, although the management of the situation should be individualised according to how
the delivery progresses, the use of EA, or foetal malposition [1,9]. For example, the Eunice Kennedy
Shriver National Institute of Child Health and Human Development document suggested allowing
one additional hour for the use of epidural analgesia. Thus, at least 3 h in multiparous women and 4 h
in nulliparous women would be considered to diagnose a prolonged second stage of labour [1].
Accordingly, many authors have studied the duration of the second stage of labour and have
based their definition on different guidelines and its relationship with neonatal morbidity. Some of
these studies have found no association between the prolonged second stage and adverse neonatal
outcomes [7,10–13]. However, other studies have observed that prolonging the second stage of labour
increases the risk of being admitted to a Neonatal Intensive Care Unit (NICU) or a low 5-min Apgar
score [2,3,14–19].
Reducing the duration of the second stage of labour by obstetric interventionism is not
a complication-free solution as, paradoxically, some of these interventions include immediate pushing
(initiated as soon as complete dilation is identified) [20], fundal pressure [21], or instrumental birth [22],
actions that may increase the risk of neonatal morbidity.
Therefore, given today’s high level of uncertainty and the important implications that the time
limitation of the second stage of labour has for the clinical practice, we propose conducting this
study to assess the relationship between the duration of the second stage of labour and the neonatal
morbidity risk.
2. Materials and Methods
2.1. Design and Participants
An observational, analytical, retrospective cohort study was done on a sample of 3863 women
who had given birth vaginally at the “Mancha-Centro Hospital” in Spain, during the 2013–2016
period. This is a Level II centre attending nearly 1300 births a year, and the hospital’s global rate of
caesareans amounts to 25.3%. The vaginal delivery rate after a previous caesarean section was 38%.
The centre has a NICU and, in labours without complications, the main responsible professionals are
the midwives, while in the case of labours with complications or instrumental labours, this role is
played by obstetricians. For the limitation of the duration of the first and second stages of labour,
the recommendations by the Spanish GPC are followed as a guideline. Regarding induced labours,
induction failure is diagnosed if, after 12 h of labour with regular uterine dynamics, the active phase of
labour was not reached. In this active phase, non-progressive labour is considered when there are no
changes regarding cervical dilatation during 4 h with regular uterine dynamics.
A prolonged second stage of labour had been defined as a period of time that lasted beyond 3 h
with EA or 2 h without EA for multiparous women. As for nulliparous women, a second prolonged
stage is defined as a period of time longer than 4 h with EA or longer than 3 h without EA.
The inclusion criterion was vaginal births, including cephalic presentation and singleton births.
Any births with a gestational age <35 weeks and with antepartum foetal death were excluded.
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2.2. Sources of Information
For data collection, the women’s medical records and those of the study neonates were used.
The following variables were considered. The “primary outcome” variable was neonatal
morbidity, which was divided into four types—pH <7.10, 5-min Apgar scores <7, advanced neonatal
resuscitation (type III: Oxygen therapy with positive intermittent pressure, IV: Endotracheal intubation,
V: Cardiac massage and/or using drugs), and composite neonatal morbidity (the combination of any
of these three types). Umbilical cord arterial pH is one of the best predictors of perinatal adverse
outcomes [23,24], and the threshold pH for adverse neurological outcomes is 7.10 [25]. The Apgar
score describes the condition of the newborn infant immediately after birth and, when properly
applied, it is a tool for standardised assessment. If the Apgar score at 5 min is greater than or equal
to 7, it is unlikely that peripartum hypoxia–ischemia causes neonatal encephalopathy [26]. The main
independent variable was the duration of the second stage of labour (up to 1 h/1–2 h/2–3 h/≥3 h).
The secondary independent variables taken into account as potentially confounding factors
were neonatal birth weight (≤2500 g/2500–3999 g/≥4000 g), labour induction (yes/no),
gestational age (<37 weeks/37–41 weeks/>41 weeks), duration of the first stage of labour (up to
3 h/>3–6 h/>6–9 h/>9 h), epidural analgesia (yes/no), type of birth (normal/instrumental), maternal
age (≤35 years/>35 years), and previous caesarean birth in multiparous women (yes/no).
Statistical Analysis Used
A univariate analysis of the potentially predictive factors was carried out by using the Chi-squared
tests to calculate the categorical variables, stratified for nulliparous and multiparous women
(Tables 1 and 2). Then, a multivariate analysis was performed by binary logistic regression, where all
the variables considered potential risk factors of neonatal morbidity for both nulliparous and
multiparous women were used. The statistical analysis was performed in a stratified way for
nulliparous and multiparous, since the parity variable is considered an effect modifying factor.
Table 1. Univariate analysis for neonatal morbidity in nulliparous women.
KERRYPNX
pH
(n = 1554)
(Missing = 164)
5-min Apgar Score
(n = 1718)
Advanced Neonatal
Resuscitation
(n = 1718)
Composite Neonatal
Morbidity
(n = 1718)
Variables <7.10 ≥7.10 <7 ≥7 Yes No Yes No
Neonatal birth weight (g)
2500–3999 g 31 (2.1) 1412(97.9) 5 (0.3)
1593
(99.7) 54 (3.4)
1544
(96.6) 81 (5.1)
1517
(94.9)
<2500 g 1 (1.4) 69 (98.6) 1 (1.3) 76 (98.7) 3 (3.9) 74 (96.1) 3 (3.9) 74 (96.1)
>4000 g 1 (2.4) 40 (97.6) 0 (0.0) 43 (100.0) 0 (0.0) 43 (100.0) 1 (2.3) 42 (97.7)
p Value 0.91 0.33 0.45 0.65
Labour Induction
No 23 (2.1) 1087(97.9) 4 (0.3)
1230
(99.7) 34 (2.8)
1200
(97.2) 54 (4.4)
1180
(95.6)
Yes 10 (2.3) 434 (97.9) 2 (0.4) 482 (99.6) 23 (4.8) 461 (95.2) 31 (6.4) 453 (93.6)
p Value 0.82 0.78 0.04 0.08
Gestational Age (weeks)
<37 1 (1.7) 58 (98.3) 1 (1.6) 62 (98.4) 3 (4.8) 60 (95.2) 3 (4.8) 60 (95.2)
37–41 25 (1.9) 1283(98.2) 4 (0.3)
1445
(99.7) 45 (3.1)
1404
(96.9) 67 (4.6)
1382
(95.4)
>41 7 (3.7) 180 (96.3) 1 (0.5) 205 (99.5) 9 (4.4) 197 (95.6) 15 (7.3) 191 (92.7)
p Value 0.26 0.21 0.51 0.26
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Table 1. Cont.
KERRYPNX
pH
(n = 1554)
(Missing = 164)
5-min Apgar Score
(n = 1718)
Advanced Neonatal
Resuscitation
(n = 1718)
Composite Neonatal
Morbidity
(n = 1718)
Duration First Stage of Labour
Until 3 h 7 (1.7) 402 (98.3) 1 (0.2) 454 (99.8) 10 (2.2) 445 (97.8) 15 (3.3) 440 (96.7)
3–6 h 14 (2.2) 614 (97.8) 2 (0.3) 704 (99.7) 14 (2.0) 692 (98.0) 27 (3.8) 679 (96.2)
6–9 h 8 (2.3) 338 (97.7) 2 (0.5) 364 (99.5) 19 (5.2) 347 (94.8) 26 (7.1) 340 (92.9)
>9 h 4 (2.3) 167 (97.7) 1 (0.5) 190 (99.5) 14 (7.3) 177 (92.7) 17 (8.9) 174 (91.1)
p Value 0.93 0.83 <0.001 0.002
Duration Second Stage of Labour
Until 1 h 9 (1.7) 532 (8.3) 2 (0.3) 601 (99.7) 15 (2.5) 588 (97.5) 24 (4.0) 579 (96.0)
1–2 h 12 (2.8) 419 (97.2) 2 (0.4) 469 (99.6) 19 (4.0) 452 (96.0) 27 (5.7) 444 (94.3)
2–3 h 7 (2.3) 294 (97.7) 1 (0.3) 339 (99.7) 12 (3.5) 328 (96.5) 19 (5.6) 321 (94.4)
≥3 h 5 (1.8) 276 (98.2) 1 (0.3) 303 (99.7) 11 (3.6) 293 (96.4) 15 (4.9) 289 (95.1)
p Value 0.64 0.99 0.54 0.55
Epidural Analgesia
No 2 (1.9) 106 (98.1) 0 (0.0) 121(100.0) 1 (0.8) 120 (99.2) 3 (2.5) 118 (97.5)
Yes 31 (2.1) 1415(97.9) 6 (0.4)
1591
(99.6) 56 (3.5)
1541
(96.5) 82 (5.1)
1515
(94.9)
p Value 0.84 0.50 0.11 0.19
Mode of birth
Normal birth 22 (1.7) 1298(98.3) 4 (0.3)
1463
(99.7) 41 (2.8)
1426
(97.2) 60 (4.1)
1407
(95.9)
Instrumental birth 11 (4.7) 223 (95.3) 2 (0.8) 249 (99.2) 16 (6.4) 235 (93.6) 25 (10.0) 226 (90.0)
p Value 0.003 0.19 0.003 <0.001
Maternal age (years)
≤35 26 (1.9) 1342(98.1) 5 (0.3)
1510
(99.7) 47 (3.1)
1468
(96.9) 70 (4.6)
1445
(95.4)
>35 7 (3.8) 179 (96.2) 1 (0.5) 202 (99.5) 10 (4.9) 193 (95.1) 15 (7.4) 188 (92.6)
p Value 0.09 0.71 0.17 0.09
Bold: Significant results are highlighted.
Table 2. Univariate analysis for neonatal morbidity in multiparous women.
pH
(n = 1912)
(Missing = 233)
5-min Apgar Score
(n = 2145)
Advanced Neonatal
Resuscitation
(n = 2145)
Composite Neonatal
Morbidity
(n = 2145)
Variables <7.10 ≥7.10 <7 ≥7 Yes No Yes No
Neonatal Birth Weight (g)
2500–3999 g 37 (2.1) 1694(97.9) 3 (0.2)
1944
(99.8) 37 (1.9)
1910
(98.1) 68 (3.5)
1879
(96.5)
<2500 r 2 (3.4) 57 (96.6) 0 (0.0) 66 (100.0) 4 (6.1) 62 (93.9) 6 (9.1) 60 (90.9)
>4000 g 1 (0.8) 121 (99.2) 0 (0.0) 132(100.0) 1 (0.8) 131 (99.2) 2 (1.5) 130 (98.5)
p Value 0.48 0.86 0.03 0.02
Labour Induction
No 24 (1.6) 1475(98.4) 2 (0.1)
1685
(99.9) 27 (1.6)
1660
(98.4) 47 (2.8)
1640
(97.2)
Yes 16 (3.9) 397 (96.1) 1 (0.2) 457 (99.8) 15 (3.3) 443 (96.7) 29 (6.3) 429 (93.7)
p Value 0.004 0.61 0.02 <0.001
Gestational Age (weeks)
<37 1 (1.7) 59 (98.3) 0 (0.0) 66 (100.0) 1 (1.5) 65 (98.5) 2 (3.0) 64 (97.0)
37–41 36 (2.2) 1614(97.8) 3 (0.2)
1850
(99.8) 34 (1.8)
1819
(98.2) 64 (3.5)
1789
(96.5)
>41 3 (1.5) 199 (98.5) 0 (0.0) 226(100.0) 7 (3.1) 219 (96.9) 10 (4.4) 216 (95.6
p Value 0.79 0.79 0.42 0.74
Duration First Stage of Labour
Until 3 h 17 (1.6) 1020(98.4) 2 (0.2)
1176
(99.8) 13 (1.1)
1165
(98.9) 27 (2.3)
1151
(97.7)
3–6 h 13 (2.0) 622 (98.0) 1 (0.1) 710 (99.9) 17 (2.4) 694 (97.6) 29 (4.1) 682 (95.9)
6–9 h 7 (3.9) 173 (96.1) 0 (0.0) 191(100.0) 7 (3.7) 184 (96.3) 13 (6.8) 178 (93.2)
>9 h 3 (5.0) 57 (95.0) 0 (0.0) 65 (100.0) 5 (7.7) 60 (92.3) 7 (10.8) 58 (89.2)
p Value 0.09 0.93 <0.001 <0.001
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Table 2. Cont.
pH
(n = 1912)
(Missing = 233)
5-min Apgar Score
(n = 2145)
Advanced Neonatal
Resuscitation
(n = 2145)
Composite Neonatal
Morbidity
(n = 2145)
Duration Second Stage of Labour
Until 1 h 27 (1.9) 1385(98.1) 2 (0.1)
1587
(99.9) 22 (1.4)
1567
(98.6) 46 (2.9)
1543
(97.1)
1–2 h 7 (2.3) 291 (97.7) 0 (0.0) 327(100.0) 13 (4.0) 314 (96.0) 18 (5.5) 309 (94.5)
2–3 h 3 (2.0) 145 (98.0) 1 (0.6) 164 (99.4) 4 (2.4) 161 (97.6) 6 (3.6) 159 (96.4)
≥3 h 3 (5.6) 51 (94.4) 0 (0.0) 64 (100.0) 3 (4.7) 61 (95.3) 6 (9.4) 58 (90.6)
p Value 0.32 0.37 0.006 0.007
Epidural Analgesia
No 7 (1.7) 397 (98.3) 0 (0.0) 470(100.0) 0 (0.0)
470
(100.0) 7 (1.5) 463 (98.5)
Yes 33 (2.2) 1475(97.8) 3 (0.2)
1672
(99.8) 42 (2.5)
1633
(97.5) 69 (4.1)
1606
(95.9)
p Value 0.57 0.36 0.001 0.006
Mode of Birth
Normal birth 33 (1.8) 1812(98.2) 3 (0.1)
2067
(99.9) 33 (1.6)
2037
(98.4) 61 (2.9)
2009
(97.1)
Instrumental birth 7 (10.4) 60 (89.6) 0 (0.0) 75 (100.0) 9 (12.0) 66 (88.0) 15 (20.0) 60 (80.0)
p Value <0.001 0.74 <0.001 0.013
Maternal Age (years)
≤35 21 (1.6) 1324(98.4) 1 (0.1)
1511
(99.9) 23 (1.5)
1489
(98.5) 41 (2.7)
1471
(97.3)
>35 19 (3.4) 548 (96.6) 2 (0.3) 631 (99.7) 19 (3.0) 614 (97.0) 35 (5.5) 598 (94.5)
p Value 0.01 0.16 0.02 0.001
Previous Cesarean Birth
No 31 (1.8) 1683(98.2) 2 (0.1)
1926
(99.9) 34 (1.8)
1894
(98.2) 60 (3.1)
1868
(96.9)
Yes 9 (4.5) 189 (95.5) 1 (0.5) 216 (99.5) 8 (3.7) 209 (96.3) 16 (7.4) 201 (92.6)
p Value 0.011 0.18 0.05 0.001
Bold: Significant results are highlighted.
The “primary outcome” variable was a composite of neonatal morbidity (CNM yes/no) (Table 3).
The results were analysed using the SPSS 24.0 statistical package (SPSS Inc., Chicago, IL, USA).
Table 3. Multivariate analysis for composite neonatal morbidity in nulliparous and
multiparous women.
Nulliparous Women
(n = 1718)
Multiparous Women
(n = 2145)
Variables OR (95% CI) p Value OR (95% CI) p Value
Neonatal Birth Weight (g)
2500–3999 g (Reference) 0.78 0.07
<2500 g 0.83 (0.24–2.87) 0.78 2.78 (1.02–7.58) 0.04
>4000 g 0.42 (0.06–3.17) 0.40 0.47 (0.11–1.98) 0.30
Labour Induction 0.65 0.13
No (Reference)
Yes 1.12 (0.69–1.84) 1.52 (0.88–2.62)
Gestational Age (weeks) 0.61 0.55
37–41 (Reference)
<37 1.14 (0.33–3.90) 0.84 0.47 (0.10–2.11) 0.32
>41 1.36 (0.74–2.49) 0.32 1.17 (0.57–2.40) 0.68
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Table 3. Cont.
Nulliparous Women
(n = 1718)
Multiparous Women
(n = 2145)
Variables OR (95% CI) p Value OR (95% CI) p Value
Duration First Stage of Labour 0.08 0.30
Until 3 h (Reference)
3–6 h 0.99 (0.51–1.95) 0.98 1.39 (0.79–2.46) 0.25
6–9 h 1.70 (0.84–3.44) 0.14 1.62 (0.75–3.50) 0.22
>9 h 2.06 (0.94–4.50) 0.07 2.37 (0.90–6.25) 0.08
Duration Second Stage of Labour 0.59 0.48
Until 1 h (Reference)
1–2 h 1.30 (0.73–2.33) 0.37 1.39 (0.76–2.51) 0.28
2–3 h 1.10 (0.58–2.11) 0.76 0.87 (0.35–2.14) 0.76
≥3 h 0.83 (0.41–1.68) 0.60 1.79 (0.66–4.85) 0.25
Epidural Analgesia 0.58 0.20
No (Reference)
Yes 1.42 (0.41–4.96) 1.73 (0.74–4.04)
Type of Birth 0.002 <0.001
Normal birth (Reference)
Instrumental birth 2.33 (1.38–3.96) 5.37 (2.73–10.56)
Maternal Age (years) 0.23 0.006
≤35 (Reference)
>35 1.44 (0.79–2.60) 1.97 (1.22–3.17)
Bold: Significant results are highlighted.
2.3. Ethical–Legal Considerations
This study was approved by the centre’s Ethics in Clinical Research Committee, which guaranteed
the confidentiality of the medical records and the information they contained at all times.
3. Results
The study was initiated with a reference population of 3907 women, and after applying the
exclusion criteria, the study population consisted of 3863 women. Of these, 1718 (44.5%) women
were nulliparous and 2145 (55.5%) were multiparous (Figure 1). The information was complete for all
the studied variables except for umbilical cord arterial pH, as this type of data was not recorded for
164 nulliparous and 233 multiparous women.
Once the univariate analysis was performed considering the potential risk factors, and the
variables were used as the neonatal morbidity criteria according to parity, we observed a statistically
significant relationship in both the nulliparous and multiparous women (p≤ 0.05) between the duration
of the first stage of labour and the degree of advanced neonatal resuscitation, as well as with composite
morbidity. In addition, a statistically significant association was found between the type of birth and
pH <7.10, advanced neonatal resuscitation, and composite morbidity (Tables 1 and 2).
Moreover, a statistically significant relationship was found only in nulliparous women for labour
induction with advanced neonatal resuscitation (Table 1).
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Figure 1. Selection of the study subjects.
Regarding multiparous women, a statistically significant relationship was found for labour
induction with pH <7.10 and composite neonatal morbidity; for the duration of the second stage of
labour with advanc d neonatal resuscitation and composite neonatal morbidity; for epidural analgesia
with both advanced neonatal resuscit tion and composite ne n al morbidity; for maternal age with
pH <7.10, advanced neonatal resuscitation, and composite neonatal morbidity; and for having had
a previous caesarean birth in multiparous women with pH <7.10 and composite morbidity (Table 2).
Neither the neonatal birth weight nor gestational age was statistically related to any of the neonatal
morbidity variables studied in multiparous women.
None of the studied risk factors was statistically relat d t 5- in Apgar score <7 in both
nulliparous and multiparous wom n.
Then, a multivariate analysis was performed for the variable “composite morbidity” in both
nulliparous and multiparous women (Table 3). In both groups, a statistically significant relationship
was found with the type of birth, and in such a way that instrumental birth increased the risk
of composite eonatal morbidity in nulliparous (odds ratio (OR), 2.33; 95% confidence interval
(CI), 1.38–3.96), and i arous women (OR, 5.37; 95% CI, 2.73–10.56). A statistically significant
relationship was also found regarding multiparous women between neonatal birth weight and
maternal age, where a low birth weight implied a higher risk of composite neonatal morbidity than
a normal birth weight (OR, 2.78; 95% CI, 1.02–7.58). Maternal age >35 years also increased the risk of
composite morbidity (OR, 1.97; 95% CI, 1.22–3.17). No statistically significant relationship was found
between composite neonatal mo bidity and labour induction, gestational ge, duration of the first
stage of l bour, duration of the second stage of labour, or epidural analgesia.
4. Discussion
The objective of this study was to assess the relationship between the duration of the second
stage of labour and the different neonatal morbidity criteria. No relationship between the duration
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of the second stage of labour and an increased risk of neonatal morbidity was observed in the
study population.
Several authors have studied the influence of the duration of the second stage of labour on
maternal and neonatal outcomes [2,3,7,10–19,27]. Most studies have found a relationship between
the duration of the second stage of labour and an increased risk of neonatal morbidity [2,3,14–19].
Some particularly relevant works are those by Sandström et al. [2], Grobman et al. [19],
Laughon et al. [18], and Zipori et al. [27], given their large sample sizes and their recent publication.
However, they were all observational studies and, as their authors state, their design did not allow
to establish any causality relationship. None of the four above-cited works evaluated the influence
of instrumental birth as a potential risk factor for neonatal morbidity. Especially interesting is the
study published by Zippori et al. [27]. This study was based on two large cohorts separated in
time, with changes in the clinical management of the duration of the second stage of labour. In this
study, it was found that the extension of the second stage of labour decreased the risk of a caesarean
section but increased neonatal morbidity. However, the authors performed a confusion control
through multivariate analysis techniques for the study of neonatal morbidity, only regarding maternal
morbidity. In addition, changes may have occurred in the clinical practice regarding the second cohort
with respect to the first one, which may have been responsible for the increase of neonatal morbidity.
Conversely, fewer recently published works have found similar results to those reported
herein [7,10–13]. In this respect, it is worth highlighting the work by Gimovsky et al. [13], as it is the
only randomised controlled trial conducted on this issue. These authors studied 78 nulliparous women
and concluded that extending the duration of the second stage of labour beyond 1 h, as compared
to the recommendations stated in traditional guidelines [8], was not related with increased neonatal
morbidity. However, a potential limitation of this study was the relatively small number of women
included. Besides, the trial was underpowered to detect small, but clinically important differences
regarding the frequency of adverse outcomes between groups. The study by Altman et al. [11] also
stands out as a systematic review that found no association between the duration of the second
stage of labour and adverse neonatal outcomes. However, inherent methodological limitations were
made evident in the studies. Recurrent limitations included the oversimplified categorisation of the
second stage, inconsistencies between the study population characteristics, and the lack of control of
confounding factors [11].
We consider that some of the differences observed between the aforementioned studies and the
present study could be explained by the differences in the studied women, the different neonatal
morbidity criteria used, and variability in the clinical practice of both centres and of the professionals
involved (midwives, gynaecologists, anaesthesiologists, and paediatricians). Hence, caution is
needed when making recommendations for setting a time limit of the second stage of labour if
no maternal/foetal risk criteria exist. Setting a time limit of the second stage of labour as a single
finishing criterion could increase the practice of instrumental birth and caesarean section, which would,
in turn, increase the risk of other associated complications [8,22].
We observed how other factors such as the type of birth, maternal age, and neonatal birth weight
are related to a high composite morbidity risk. Indeed, instrumental births had more than 2-fold
risk of neonatal morbidity than normal births for nulliparous women, and this risk was more than
5-fold for multiparous women. In line with this, other authors have found similar findings [22,28,29].
However, it is necessary to be cautious about this association as our study design does not allow
causality relationships. It was not possible to establish a separation between the morbidity produced
exclusively by practicing instrumental birth and the morbidity before instrumental birth being
practiced to lower it [30]. All in all, our results lead to considering restricting instrumental births
in those clinical risk situations that may require this practice, and not just following the criterion of
limiting the duration of the second stage of labour.
As for maternal age, multiparous women aged more than 35 years were at higher risk of composite
neonatal morbidity. Our results were similar to those reported in other studies [31,32] in which
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advanced maternal age obtained worse neonatal outcomes. This could be due to the fact that signs of
accelerated placental ageing, altered nutrient transport, and vascular function are observed in women
of advanced maternal age [33].
Regarding the neonatal birth weight, an increased composite morbidity in those neonates whose
birth weight was below 2500 g and who were born to multiparous women was found in our study.
These results coincide with other studies done on this same issue [34,35].
The present study is not without its limitations, which are inherent to retrospective studies.
For example, no records were taken of active maternal effort times. It would be valuable to know if
maternal pushing time is related to neonatal morbidity, as well as to know other neonatal morbidity
variables like being admitted to an NICU, long hospital stays for neonates, or possible complications
that could appear in the long term. Other important limitations in our study are the lack of information
on certain variables such as the presence of gestational diabetes, maternal body mass index, and the
use of labour augmentation with oxytocin. Finally, another limitation was the lack of record of some
umbilical cord arterial pH values, favoured by practicing delayed umbilical cord clamping and by
determination errors. However, we considered that in most cases in which it was not possible to
establish umbilical cord arterial pH values, the results would not be pathologic because our centre
prioritises obtaining a sample before practicing delayed umbilical cord clamping if loss of foetal
wellbeing may be expected.
On the other hand, this study has its strengths. It is the most recent study which finds no
relationship between the duration of the second stage of labour and neonatal morbidity. We also
employed techniques to control confounders by a multivariate analysis technique. Another strength
is having employed objective variables like umbilical cord arterial pH and a variable that combines
different criteria to obtain a more global neonatal morbidity assessment.
5. Conclusions
The duration of the second stage of labour is not related with neonatal morbidity in our study
population. Shortening this stage of labour with obstetric interventions should be based on criteria
other than preventing neonatal adverse outcomes. This conclusion will allow for the reinforcement of
the recommendation that the duration of the second stage of labour must not be exclusively limited by
time criteria by conferring women more probabilities of vaginal birth.
Author Contributions: Conceptualization, N.I.-T. and A.R.-A.; methodology, A.R.-A. and J.G.-S.; formal analysis,
A.H.-M. and J.R.-A.; writing—original draft preparation, M.M.-A. and N.I.-T.; writing—review and editing, J.G.-S.
and J.R.-A.; supervision, A.H.-M. and M.M.-A.; project administration, N.I.-T.
Acknowledgments: We would like to thank the Professional Nursing College of Ciudad Real for awarding us
with the regional prize for the best nursing research paper of Castilla la Mancha (Spain, 20th Edition).
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Obstetric Care Consensus no. 1: Safe Prevention of the Primary Cesarean Delivery.Obstet. Gynecol. 2014, 123, 693–711.
[CrossRef]
2. Sandström, A.; Altman, M.; Cnattingius, S.; Johansson, S.; Ahlberg, M.M.; Stephansson, O. Durations of
second stage of labour and pushing, and adverse neonatal outcomes: A population-based cohort study.
J. Perinatol. 2017, 37, 236–242. [CrossRef]
3. Bleich, A.T.T.; Alexander, J.M.M.; McIntire, D.D.D.; Leveno, K.J. An analysis of second-stage labour beyond
3 h in nulliparous women. Am. J. Perinatol. 2012, 29, 717–722.
4. Hunt, J.C.C.; Menticoglou, S.M. Perinatal Outcome in 1515 Cases of Prolonged Second Stage of Labour in
Nulliparous Women. J. Obstet. Gynaecol. Can. 2015, 37, 508–516. [CrossRef]
5. Janakiraman, V.V.; Ecker, J.J.; Kaimal, A.J. Comparing the second stage in induced and spontaneous labour.
Obstet. Gynecol. 2010, 116, 606–611. [CrossRef]
J. Clin. Med. 2019, 8, 376 10 of 11
6. Cheng, Y.W.W.; Hopkinsm, L.M.M.; Caugheym, A.B. How long is too long: Does a prolonged second stage of labour
in nulliparous women affect maternal and neonatal outcomes? Am. J. Obstet. Gynecol. 2004, 191, 933–938. [CrossRef]
7. Le Ray, C.C.; Audibert, F.F.; Goffinet, F.F.; Fraser, W. When to stop pushing: Effects of duration of second-stage
expulsion efforts on maternal and neonatal outcomes in nulliparous women with epidural analgesia. Am. J.
Obstet. Gynecol. 2009, 201, 361.e1–361.e7. [CrossRef] [PubMed]
8. American College of Obstetricians and Gynecologists. Operative Vaginal Delivery. Practice Bulletin No. 17.
Obstet. Gynecol. 2012, 126, e56–e65.
9. National Institute for Health and Care Excellence. Intrapartum care: Care of healthy women and their babies
during childbirth. NICE Clin. Guidel. 2014, 190, 805.
10. Myles, T.D.; Santolaya, J. Maternal and neonatal outcomes in patients with a prolonged second stage
of labour. Obstet. Gynecol. 2003, 102, 52–58. [PubMed]
11. Altman, M.R.; Lydon-Rochelle, M.T. Prolonged second stage of labour and risk of adverse maternal and
perinatal outcomes: A systematic review. Birth 2006, 33, 315–322. [CrossRef]
12. Naime-Alix, A.-F.; Fourquet, F.; Sigue, D.; Potin, J.; Descriaud, C.; Perrotin, F. [How long can we wait at full
dilatation. A study of maternal and neonatal morbidity related to the duration of the second stage of labour
in nulliparous women]. J. Gynecol. Obstet. Biol. Reprod. 2008, 37, 268–275. [CrossRef]
13. Gimovsky, A.C.; Berghella, V. Randomized controlled trial of prolonged second stage: Extending the time
limit vs usual guidelines. Am. J. Obstet. Gynecol. 2016, 214, 361.e1–361.e6.
14. Cheng, Y.W.; Hopkins, L.M.; Laros, R.K., Jr.; Caughey, A.B. Duration of the second stage of labour in
multiparous women: Maternal and neonatal outcomes. Am. J. Obstet. Gynecol. 2007, 196, 585.e1–585.e6.
[CrossRef]
15. Cheng, Y.W.; Shaffer, B.L.; Nicholson, J.M.; Caughey, A.B. Second stage of labour and epidural use: A larger
effect than previously suggested. Obstet. Gynecol. 2014, 123, 527–535. [CrossRef]
16. Allen, V.M.; Baskett, T.F.; O’Connell, C.M.; McKeen, D.; Allen, A.C. Maternal and perinatal outcomes with
increasing duration of the second stage of labour. Obstet. Gynecol. 2009, 113, 1248–1258. [CrossRef]
17. Rouse, D.J.; Weiner, S.J.; Bloom, S.L.; Varner, M.W.; Spong, C.Y.; Ramin, S.M.; Caritis, S.N.; Peaceman, A.M.;
Sorokin, Y.; Sciscione, A.; et al. Second-stage labour duration in nulliparous women: Relationship to maternal
and perinatal outcomes. Am. J. Obstet. Gynecol. 2009, 201, 357.e1–357.e7. [CrossRef]
18. Laughon, S.K.; Berghella, V.; Reddy, U.M.; Sundaram, R.; Lu, Z.; Hoffman, M.K. Neonatal and maternal
outcomes with prolonged second stage of labour. Obstet. Gynecol. 2014, 124, 57–67. [CrossRef]
19. Grobman, W.A.; Bailit, J.; Lai, Y.; Reddy, U.M.; Wapner, R.J.; Varner, M.W.; Caritis, S.N.; Prasad, M.; Tita, A.T.;
Saade, G.; et al. Association of the duration of active pushing with obstetric outcomes. Obstet. Gynecol. Dept.
2016, 127, 667–673. [CrossRef]
20. Simpson, K.; James, D. Effects of immediate versus delayed pushing during second-stage labour on fetal
well-being: A randomized clinical trial. Nurs. Res. 2005, 54, 149–157. [CrossRef]
21. Moiety, F.M.S.; Azzam, A.Z. Fundal pressure during the second stage of labour in a tertiary obstetric center:
A prospective analysis. J. Obstet. Gynaecol. Res. 2014, 40, 946–953. [CrossRef] [PubMed]
22. Thavarajah, H.; Flatley, C.; Kumar, S. The relationship between the five minute Apgar score, mode of birth
and neonatal outcomes. J. Matern. Neonatal. Med. 2018, 31, 1335–1341. [CrossRef] [PubMed]
23. Georgieva, A.; Moulden, M.; Redman, C.W.G. Umbilical cord gases in relation to the neonatal condition:
The EveREst plot. Eur. J. Obstet. Gynecol. Reprod. Biol. 2013, 168, 155–160. [CrossRef]
24. Malin, G.L.; Morris, R.K.; Khan, K.S. Strength of association between umbilical cord pH and perinatal and
long term outcomes: Systematic review and meta-analysis. BMJ 2010, 340, c1471. [CrossRef]
25. Yeh, P.; Emary, K.; Impey, L. The relationship between umbilical cord arterial pH and serious adverse
neonatal outcome: Analysis of 51◦519 consecutive validated samples. BJOG 2012, 119, 824–831. [CrossRef]
26. The American College of Obstetricians and Gynecologists Committee Opinion no. 644: The Apgar Score.
Obstet. Gynecol. 2015, 126, e52–e55. [CrossRef]
27. Zipori, Y.; Grunwald, O.; Ginsberg, Y.; Beloosesky, R.; Weiner, Z. The impact of extending the second stage
of labor to prevent primary cesarean delivery on maternal and neonatal outcomes. Am. J. Obstet. Gynecol.
2019, 220, 191.e1–191.e7. [CrossRef]
28. Demissie, K.; Rhoads, G.G.; Smulian, J.C.; Balasubramanian, B.A.; Gandhi, K.; Joseph, K.S.; Kramer, M.
Operative vaginal delivery and neonatal and infant adverse outcomes: Population based retrospective
analysis. BMJ 2004, 329, 24. [CrossRef]
J. Clin. Med. 2019, 8, 376 11 of 11
29. US Food and Drug Administration Center for Devices and Radiological Health. FDA Public Health Advisory:
Need for Caution When Using Vacuum Assisted Delivery Devices; FDA: Rockville, MD, USA, 1998.
30. The American College of Obstetricians and Gynecologists Practice Bulletin No. 154 Summary:
Operative Vaginal Delivery. Obstet. Gynecol. 2015, 126, 1118–1119. [CrossRef]
31. Blomberg, M.; Birch Tyrberg, R.; Kjølhede, P. Impact of maternal age on obstetric and neonatal outcome with
emphasis on primiparous adolescents and older women: A Swedish Medical Birth Register Study. BMJ Open
2014, 4, e005840. [CrossRef]
32. Cakmak Celik, F.; Aygun, C.; Kucukoduk, S.; Bek, Y. Maternal and neonatal outcomes in advanced maternal
age: A retrospective cohort study. J. Matern. Neonatal. Med. 2017, 30, 2452–2456. [CrossRef] [PubMed]
33. Lean, S.C.; Heazell, A.E.P.; Dilworth, M.R.; Mills, T.A.; Jones, R.L. Placental Dysfunction Underlies Increased
Risk of Fetal Growth Restriction and Stillbirth in Advanced Maternal Age Women. Sci. Rep. 2017, 7, 9677.
[CrossRef] [PubMed]
34. Dowdall, D.; Flatley, C.; Kumar, S. Birth weight centiles, risk of intrapartum compromise, and adverse
perinatal outcomes in term infants. J. Matern. Neonatal. Med. 2017, 30, 2126–2132. [CrossRef]
35. Yu, J.; Flatley, C.; Greer, R.M.; Kumar, S. Birth-weight centiles and the risk of serious adverse neonatal
outcomes at term. J. Perinat. Med. 2018, 46, 1048–1056. [CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
